{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:45:04Z","timestamp":1791305104513,"version":"4.3.1"},"reference-count":155,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"DOI":"10.1093\/carcin\/bgi274","type":"journal-article","created":{"date-parts":[[2005,11,25]],"date-time":"2005-11-25T01:12:41Z","timestamp":1132881161000},"page":"673-681","source":"Crossref","is-referenced-by-count":59,"title":["Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications"],"prefix":"10.1093","volume":"27","author":[{"given":"Yulia","family":"Tabakin-Fix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Azran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Schavinky-Khrapunsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mordechai","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,11,23]]},"reference":[{"key":"key\n\t\t\t\t20171011194006_B1","doi-asserted-by":"crossref","unstructured":"Suzuki,Y. and Gojobori,T. ( 1998 ) The origin and evolution of human T-cell lymphotropic virus types I and II. Virus Genes , 16 , 69 \u201384.","DOI":"10.1023\/A:1007953826869"},{"key":"key\n\t\t\t\t20171011194006_B2","doi-asserted-by":"crossref","unstructured":"Vandamme,A.-M., Salemi,M. and Desmyter,J. ( 1998 ) The simian origins of the pathogenic human T-cell lymphotropic virus type I. Trends Microbiol. , 6 , 477 \u2013483.","DOI":"10.1016\/S0966-842X(98)01406-1"},{"key":"key\n\t\t\t\t20171011194006_B3","doi-asserted-by":"crossref","unstructured":"Morgan,D.A., Ruscetti,F.W. and Gallo,R. ( 1976 ) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science , 193 , 1007 \u20131008.","DOI":"10.1126\/science.181845"},{"key":"key\n\t\t\t\t20171011194006_B4","doi-asserted-by":"crossref","unstructured":"Ruscetti,F.W., Morgan,D.A. and Gallo,R.C. ( 1977 ) Functional and morphologic characterization of human T cells continuously grown in vitro . J. Immunol. , 119 , 131 \u2013138.","DOI":"10.4049\/jimmunol.119.1.131"},{"key":"key\n\t\t\t\t20171011194006_B5","doi-asserted-by":"crossref","unstructured":"Gootenberg,J.E., Ruscetti,F.W., Mier,J.W., Gazdar,A. and Gallo,R.C. ( 1981 ) Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor. J. Exp. Med. , 154 , 1403 \u20131418.","DOI":"10.1084\/jem.154.5.1403"},{"key":"key\n\t\t\t\t20171011194006_B6","doi-asserted-by":"crossref","unstructured":"Mier,J.W. and Gallo,R.C. ( 1982 ) The purification and properties of human T cell growth factor. J. Immunol. , 128 , 1122 \u20131127.","DOI":"10.4049\/jimmunol.128.3.1122"},{"key":"key\n\t\t\t\t20171011194006_B7","doi-asserted-by":"crossref","unstructured":"Poiesz,B.J., Ruscetti,F.W., Gazdar,A.F., Bunn,P.A., Minna,J.D. and Gallo,R.C. ( 1980 ) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl Acad. Sci. USA , 77 , 7415 \u20137419.","DOI":"10.1073\/pnas.77.12.7415"},{"key":"key\n\t\t\t\t20171011194006_B8","doi-asserted-by":"crossref","unstructured":"Yoshida,M., Miyoshi,I. and Hinuma,Y. ( 1982 ) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl Acad. Sci. USA , 79 , 2031 \u20132035.","DOI":"10.1073\/pnas.79.6.2031"},{"key":"key\n\t\t\t\t20171011194006_B9","doi-asserted-by":"crossref","unstructured":"Uchiyama,T., Yodoi,J., Sagawa,K., Takatsuki,K. and Uchino,H. ( 1977 ) Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood , 50 , 481 \u2013492.","DOI":"10.1182\/blood.V50.3.481.481"},{"key":"key\n\t\t\t\t20171011194006_B10","unstructured":"Takatsuki,K., Uchiyama,T. and Yodoi,J. ( 1977 ) Adult T-cell leukemia in Japan. In : Topics in Hematology . Excerpta Medic, Amsterdam."},{"key":"key\n\t\t\t\t20171011194006_B11","doi-asserted-by":"crossref","unstructured":"Gessain,A., Barin,F., Vernant,J.C., Gout,O., Maurs,L., Calender,A. and de The,G. ( 1985 ) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet , 2 , 407 \u2013410.","DOI":"10.1016\/S0140-6736(85)92734-5"},{"key":"key\n\t\t\t\t20171011194006_B12","doi-asserted-by":"crossref","unstructured":"Osame,M., Usuku,K., Izumo,S., Ijichi,N., Amitani,H., Igata,A., Matsumoto,M. and Tara,M. ( 1986 ) HTLV-I associated myelopathy, a new clinical entity. Lancet , 1 , 1031 \u20131032.","DOI":"10.1016\/S0140-6736(86)91298-5"},{"key":"key\n\t\t\t\t20171011194006_B13","doi-asserted-by":"crossref","unstructured":"Proietti,F.A., Carneiro-Proietti,A.B., Catalan-Soares,B.C. and Murphy,E.L. ( 2005 ) Global epidemiology of HTLV-I infection and associated diseases. Oncogene , 24 , 6058 \u20136068.","DOI":"10.1038\/sj.onc.1208968"},{"key":"key\n\t\t\t\t20171011194006_B14","doi-asserted-by":"crossref","unstructured":"Carvalho,E.M. and Da Fonseca Porto,A. ( 2004 ) Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis . Parasite Immunol. , 26 , 487 \u2013497.","DOI":"10.1111\/j.0141-9838.2004.00726.x"},{"key":"key\n\t\t\t\t20171011194006_B15","doi-asserted-by":"crossref","unstructured":"Azran,I., Schavinsky-Khrapunsky,Y., Priel,E., Huleihel,M. and Aboud,M. ( 2004 ) Implications of the evolution pattern of human T-cell leukemia retroviruses on their pathogenic virulence (Review). Int. J. Mol. Med. , 14 , 909 \u2013915.","DOI":"10.3892\/ijmm.14.5.909"},{"key":"key\n\t\t\t\t20171011194006_B16","doi-asserted-by":"crossref","unstructured":"Azran,I., Schavinsky-Khrapunsky,Y. and Aboud,M. ( 2004 ) Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology , 1 , 20 \u201343.","DOI":"10.1186\/1742-4690-1-20"},{"key":"key\n\t\t\t\t20171011194006_B17","doi-asserted-by":"crossref","unstructured":"Jeang,K.T., Giam,C.Z., Majone,F. and Aboud,M. ( 2004 ) Life, death and Tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J. Biol. Chem. , 279 , 31991 \u201331994.","DOI":"10.1074\/jbc.R400009200"},{"key":"key\n\t\t\t\t20171011194006_B18","doi-asserted-by":"crossref","unstructured":"Taylor,G.P. and Matsuoka,M. ( 2005 ) Natural history of adult T-cell leukemia\/lymphoma and approaches to therapy. Oncogene , 24 , 6047 \u20136057.","DOI":"10.1038\/sj.onc.1208979"},{"key":"key\n\t\t\t\t20171011194006_B19","doi-asserted-by":"crossref","unstructured":"Matsuoka,M. ( 2005 ) Human T-cell leukemia virus type 1 (HTLV-1) infection and the onset of adult T-cell leukemia (ATL). Retrovirology , 2 , 27 \u201339.","DOI":"10.1186\/1742-4690-2-27"},{"key":"key\n\t\t\t\t20171011194006_B20","doi-asserted-by":"crossref","unstructured":"Matsuoka,M. and Jeang,K.T. ( 2005 ) Human T-Cell leukemia virus type I at age 25: a, progress report. Cancer Res. , 65 , 4467 \u20134470.","DOI":"10.1158\/0008-5472.CAN-05-0559"},{"key":"key\n\t\t\t\t20171011194006_B21","doi-asserted-by":"crossref","unstructured":"Takatsuki,K. ( 2005 ) Discovery of adult T-cell leukemia. Retrovirology , 2 , 16 \u201318.","DOI":"10.1186\/1742-4690-2-16"},{"key":"key\n\t\t\t\t20171011194006_B22","doi-asserted-by":"crossref","unstructured":"Nicot,C. ( 2005 ) Current views in HTLV-I-associated adult T-cell leukemia\/lymphoma. Am. J. Hematol. , 78 , 232 \u2013239.","DOI":"10.1002\/ajh.20307"},{"key":"key\n\t\t\t\t20171011194006_B23","doi-asserted-by":"crossref","unstructured":"Yoshida,M. ( 2005 ) Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene , 24 , 5931 \u20135937.","DOI":"10.1038\/sj.onc.1208981"},{"key":"key\n\t\t\t\t20171011194006_B24","doi-asserted-by":"crossref","unstructured":"Gallo,R.C. ( 2005 ) History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene , 24 , 5926 \u20135930.","DOI":"10.1038\/sj.onc.1208980"},{"key":"key\n\t\t\t\t20171011194006_B25","doi-asserted-by":"crossref","unstructured":"Gallo,R.C. ( 2005 ) The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology , 2 , 17 \u201323.","DOI":"10.1186\/1742-4690-2-17"},{"key":"key\n\t\t\t\t20171011194006_B26","unstructured":"Pise-Masison,C.A., Jeong,S.J. and Brady,J.N. ( 2005 ) Human T cell leukemia virus type 1: the role of Tax in leukemogenesis. Arch. Immunol. Ther. Exp. (Warsz) , 53 , 283 \u2013296."},{"key":"key\n\t\t\t\t20171011194006_B27","doi-asserted-by":"crossref","unstructured":"Grassmann,R., Aboud,M. and Jeang,K.T. ( 2005 ) Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene , 24 , 5976 \u20135985.","DOI":"10.1038\/sj.onc.1208978"},{"key":"key\n\t\t\t\t20171011194006_B28","doi-asserted-by":"crossref","unstructured":"Richardson,J.H., Edwards,A.J., Cruickshank,J.K., Rudge,P. and Dalgleish,A.G. ( 1990 ) In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. , 64 , 5682 \u20135687.","DOI":"10.1128\/JVI.64.11.5682-5687.1990"},{"key":"key\n\t\t\t\t20171011194006_B29","doi-asserted-by":"crossref","unstructured":"Newbound,G., Andrews,J., O'Rourke,J., Brady,J. and Lairmore,M. ( 1996 ) Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytes. J. Virol. , 70 , 2101 \u20132106.","DOI":"10.1128\/JVI.70.4.2101-2106.1996"},{"key":"key\n\t\t\t\t20171011194006_B30","doi-asserted-by":"crossref","unstructured":"Copeland,K.F. and Heeney,J.L. ( 1996 ) T helper cell activation and human retroviral pathogenesis. Microbiol. Rev. , 60 , 722 \u2013742.","DOI":"10.1128\/MMBR.60.4.722-742.1996"},{"key":"key\n\t\t\t\t20171011194006_B31","doi-asserted-by":"crossref","unstructured":"Pinsky,B.A. and Biggins,S. ( 2005 ) The spindle checkpoint: tension versus attachment. Trends Cell Biol. , 15 , 486 \u2013493.","DOI":"10.1016\/j.tcb.2005.07.005"},{"key":"key\n\t\t\t\t20171011194006_B32","doi-asserted-by":"crossref","unstructured":"Iwanaga,Y., Kasai,T., Kibler,K. and Jeang,K.T. ( 2002 ) Characterization of regions in hsMAD1 needed for binding hsMAD2. A polymorphic changes in an hsMAD1 leucine zipper affects MAD1\u2013MAD2 interaction and spindle checkpoint function. J. Biol. Chem. , 277 , 31005 \u201331013.","DOI":"10.1074\/jbc.M110666200"},{"key":"key\n\t\t\t\t20171011194006_B33","unstructured":"Iwanaga,Y. and Jeang,K.T. ( 2002 ) Expression of mitotic spindle checkpoint protein hsMAD1 correlates with cellular proliferation and is activated by a gain-of-function p53 mutant. Cancer Res. , 62 , 2618 \u20132624."},{"key":"key\n\t\t\t\t20171011194006_B34","doi-asserted-by":"crossref","unstructured":"Kops,G.J., Weaver,B.A. and Cleveland,D.W. ( 2005 ) On the road to cancer: aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer , 5 , 773 \u2013785.","DOI":"10.1038\/nrc1714"},{"key":"key\n\t\t\t\t20171011194006_B35","doi-asserted-by":"crossref","unstructured":"Marriott,S.J., Lemoine,F.J. and Jeang,K.T. ( 2002 ) Damaged DNA and miscounted chromosomes: human T cell leukemia virus type I tax oncoprotein and genetic lesions in transformed cells. J. Biomed. Sci. , 9 , 292 \u2013298.","DOI":"10.1007\/BF02256583"},{"key":"key\n\t\t\t\t20171011194006_B36","doi-asserted-by":"crossref","unstructured":"Kasai,T., Iwanaga,Y., Iha,H. and Jeang,K.T. ( 2002 ) Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors. J. Biol. Chem. , 277 , 5187 \u20135193.","DOI":"10.1074\/jbc.M110295200"},{"key":"key\n\t\t\t\t20171011194006_B37","doi-asserted-by":"crossref","unstructured":"Kamihira,S., Atogami,S., Sohda,H., Momita,S., Toryia,K., Ikeda,S., Yamada,Y. and Tomonaga,M. ( 1994 ) DNA aneuploidy of adult T-cell leukemia cells. Leuk. Res. , 18 , 79 \u201384.","DOI":"10.1016\/0145-2126(94)90122-8"},{"key":"key\n\t\t\t\t20171011194006_B38","doi-asserted-by":"crossref","unstructured":"Marriott,S.J. and Semmes,O.J. ( 2005 ) Impact of HTLV-1 Tax on cell cycle progression and cellular DNA damage repair response. Oncogene , 24 , 5986 \u20135995.","DOI":"10.1038\/sj.onc.1208976"},{"key":"key\n\t\t\t\t20171011194006_B39","doi-asserted-by":"crossref","unstructured":"Pise-Masison,C.A. and Brady,J.N. ( 2005 ) Setting the stage for transformation: HTLV-1 Tax inhibition of p53 function. Front. Biosci. , 10 , 919 \u2013930.","DOI":"10.2741\/1586"},{"key":"key\n\t\t\t\t20171011194006_B40","doi-asserted-by":"crossref","unstructured":"Stewart,Z.A. and Pietenpol,J.A. ( 2001 ) p53 Signaling and cell cycle checkpoints. Chem. Res. Toxicol. , 14 , 243 \u2013263.","DOI":"10.1021\/tx000199t"},{"key":"key\n\t\t\t\t20171011194006_B41","doi-asserted-by":"crossref","unstructured":"Fridman,J.S. and Lowe,S.W. ( 2003 ) Control of apoptosis by p53. Oncogene , 22 , 9030 \u20139040.","DOI":"10.1038\/sj.onc.1207116"},{"key":"key\n\t\t\t\t20171011194006_B42","doi-asserted-by":"crossref","unstructured":"Yu,J. and Zhang,L. ( 2005 ) The transcriptional targets of p53 in apoptosis control. Biochem. Biophys. Res. Commun. , 331 , 851 \u2013858.","DOI":"10.1016\/j.bbrc.2005.03.189"},{"key":"key\n\t\t\t\t20171011194006_B43","doi-asserted-by":"crossref","unstructured":"Ford,J.M. ( 2005 ) Regulation of DNA damage recognition and nucleotide excision repair: another role for p53. Mutat. Res. , 577 , 195 \u2013202.","DOI":"10.1016\/j.mrfmmm.2005.04.005"},{"key":"key\n\t\t\t\t20171011194006_B44","doi-asserted-by":"crossref","unstructured":"Arrowsmith,C.H. ( 1999 ) Structure and function in the p53 family. Cell Death Differ. , 6 , 1169 \u20131173.","DOI":"10.1038\/sj.cdd.4400619"},{"key":"key\n\t\t\t\t20171011194006_B45","doi-asserted-by":"crossref","unstructured":"Torgeman,A., Mor-Vaknin,N., Zelin,E., Ben-Aroya,Z., Lochelt,M., Flugel,R.M. and Aboud,M. ( 2001 ) Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12- O -tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C. Virology , 281 , 10 \u201320.","DOI":"10.1006\/viro.2000.0779"},{"key":"key\n\t\t\t\t20171011194006_B46","doi-asserted-by":"crossref","unstructured":"Abramovitch,S. and Werner,H. ( 2003 ) Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene. Horm. Metab. Res. , 35 , 758 \u2013762.","DOI":"10.1055\/s-2004-814154"},{"key":"key\n\t\t\t\t20171011194006_B47","doi-asserted-by":"crossref","unstructured":"Koutsodontis,G., Vasilaki,E., Chou,W.C., Papakosta,P. and Kardassis,D. ( 2005 ) Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis. Biochem. J. , 389 , 443 \u2013455.","DOI":"10.1042\/BJ20041980"},{"key":"key\n\t\t\t\t20171011194006_B48","doi-asserted-by":"crossref","unstructured":"Ho,J. and Benchimol,S. ( 2003 ) Transcriptional repression mediated by the p53 tumor suppressor. Cell Death Differ. , 19 , 404 \u2013408.","DOI":"10.1038\/sj.cdd.4401191"},{"key":"key\n\t\t\t\t20171011194006_B49","doi-asserted-by":"crossref","unstructured":"Prives,C. and Hall,P.A. ( 1999 ) The p53 pathway. J. Pathol. , 187 , 112 \u2013126.","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3"},{"key":"key\n\t\t\t\t20171011194006_B50","doi-asserted-by":"crossref","unstructured":"Ko,L.J. and Prives,C. ( 1996 ) p53: puzzle and paradigm. Genes Dev. , 10 , 1054 \u20131072.","DOI":"10.1101\/gad.10.9.1054"},{"key":"key\n\t\t\t\t20171011194006_B51","doi-asserted-by":"crossref","unstructured":"Oren,M. ( 1999 ) Regulation of the p53 tumor suppressor protein. J. Biol. Chem. , 274 , 36031 \u201336034.","DOI":"10.1074\/jbc.274.51.36031"},{"key":"key\n\t\t\t\t20171011194006_B52","doi-asserted-by":"crossref","unstructured":"Xu,Y. ( 2003 ) Regulation of p53 responses by post-translational modifications. Cell. Death Differ. , 10 , 400 \u2013403.","DOI":"10.1038\/sj.cdd.4401182"},{"key":"key\n\t\t\t\t20171011194006_B53","doi-asserted-by":"crossref","unstructured":"Brooks,C.L. and Gu,W. ( 2003 ) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr. Opin. Cell Biol. , 15 , 164 \u2013171.","DOI":"10.1016\/S0955-0674(03)00003-6"},{"key":"key\n\t\t\t\t20171011194006_B54","unstructured":"Shaw,P., Freeman,J., Bovey,R. and Iggo,R. ( 1996 ) Regulation of specific DNA binding by p53: evidence for a role for O -glycosylation and charged residues at the carboxy-terminus. Oncogene , 12 , 921 \u2013930."},{"key":"key\n\t\t\t\t20171011194006_B55","doi-asserted-by":"crossref","unstructured":"Shieh,S.Y., Taya,Y. and Prives,C. ( 1999 ) DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J. , 18 , 1815 \u20131823.","DOI":"10.1093\/emboj\/18.7.1815"},{"key":"key\n\t\t\t\t20171011194006_B56","doi-asserted-by":"crossref","unstructured":"Bond,G.L., Hu,W. and Levine,A.J. ( 2005 ) MDM2 is a central node in the p53 pathway: 12 years and counting. Curr. Cancer Drug Targets , 5 , 3 \u20138.","DOI":"10.2174\/1568009053332627"},{"key":"key\n\t\t\t\t20171011194006_B57","doi-asserted-by":"crossref","unstructured":"Brady,M., Vlatkovic,N. and Boyd,M.T. ( 2005 ) Regulation of p53 and MDM2 activity by MTBP. Mol. Cell. Biol. , 25 , 545 \u2013553.","DOI":"10.1128\/MCB.25.2.545-553.2005"},{"key":"key\n\t\t\t\t20171011194006_B58","unstructured":"Moll,U.M. and Petrenko,O. ( 2003 ) The MDM2\u2013p53 interaction. Mol. Cancer Res. , 1 , 1001 \u20131008."},{"key":"key\n\t\t\t\t20171011194006_B59","doi-asserted-by":"crossref","unstructured":"Kubbutat,M.H., Iones,S.N. and Vousden,K.H. ( 1997 ) Regulation of p53 stability by MDM2. Nature , 387 , 299 \u2013303.","DOI":"10.1038\/387299a0"},{"key":"key\n\t\t\t\t20171011194006_B60","doi-asserted-by":"crossref","unstructured":"Yang,Y., Li,C.C. and Weissman,A.M. ( 2004 ) Regulating the p53 system through ubiquitination. Oncogene , 23 , 2096 \u20132106.","DOI":"10.1038\/sj.onc.1207411"},{"key":"key\n\t\t\t\t20171011194006_B61","doi-asserted-by":"crossref","unstructured":"Kussie,P.H., Gorina,S., Marechal,V., Elenbaas,B., Moreau,J., Levine,A.J. and Pavletich,N.P. ( 1996 ) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science , 274 , 948 \u2013953.","DOI":"10.1126\/science.274.5289.948"},{"key":"key\n\t\t\t\t20171011194006_B62","doi-asserted-by":"crossref","unstructured":"Wsierska-Gadek,J. and Horky,M. ( 2003 ) How the nucleolar sequestration of p53 protein or its interplayers contributes to its (re)-activation. Ann. NY Acad. Sci. , 1010 , 266 \u2013272.","DOI":"10.1196\/annals.1299.046"},{"key":"key\n\t\t\t\t20171011194006_B63","doi-asserted-by":"crossref","unstructured":"Sherr,C.J. ( 2001 ) The INK4a\/ARF network in tumour suppression. Nat. Rev. Mol. Cell Biol. , 2 , 731 \u2013737.","DOI":"10.1038\/35096061"},{"key":"key\n\t\t\t\t20171011194006_B64","doi-asserted-by":"crossref","unstructured":"Lowe,S.W. and Sherr,C.J. ( 2003 ) Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Develop. , 13 , 77 \u201383.","DOI":"10.1016\/S0959-437X(02)00013-8"},{"key":"key\n\t\t\t\t20171011194006_B65","doi-asserted-by":"crossref","unstructured":"Asher,G., Lotem,J., Kama,R., Sachs,L. and Shaul,Y. ( 2002 ) MDM2 and ubiquitin-independent p53 proteosomal degradation regulated by NQO1. Proc. Natl Acad. Sci. USA , 99 , 13125 \u201313130.","DOI":"10.1073\/pnas.202480499"},{"key":"key\n\t\t\t\t20171011194006_B66","doi-asserted-by":"crossref","unstructured":"Asher,G., Tsvetkov,P., Kahana,C. and Shaul,Y. ( 2005 ) A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev. , 19 , 316 \u2013321.","DOI":"10.1101\/gad.319905"},{"key":"key\n\t\t\t\t20171011194006_B67","doi-asserted-by":"crossref","unstructured":"Shvarts,A., Steegenga,W.T., Riteco,N. et al . ( 1996 ) MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J. , 15 , 5349 \u20135357.","DOI":"10.1002\/j.1460-2075.1996.tb00919.x"},{"key":"key\n\t\t\t\t20171011194006_B68","doi-asserted-by":"crossref","unstructured":"Marine,J.C. and Jochemsen,A.G. ( 2005 ) Mdmx as an essential regulator of p53 activity. Biochem. Biophys. Res. Commun. , 331 , 750 \u2013760.","DOI":"10.1016\/j.bbrc.2005.03.151"},{"key":"key\n\t\t\t\t20171011194006_B69","doi-asserted-by":"crossref","unstructured":"Corcoran,C.A., He,Q., Huang,Y. and Sheikh,M.S. ( 2005 ) Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis. Oncogene , 24 , 1634 \u20131640.","DOI":"10.1038\/sj.onc.1208353"},{"key":"key\n\t\t\t\t20171011194006_B70","doi-asserted-by":"crossref","unstructured":"Lu,X. ( 2005 ) p53: a heavily dictated dictator of life and death. Curr. Opin. Genet. Dev. , 15 , 27 \u201333.","DOI":"10.1016\/j.gde.2004.12.008"},{"key":"key\n\t\t\t\t20171011194006_B71","doi-asserted-by":"crossref","unstructured":"Saito,S.i., Yamaguchi,H., Higashimoto,Y., Chao,C., Xu,Y., Fornace,A.J. Jr, Appella,E. and Anderson,C.W. ( 2003 ) Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. , 278 , 37536 \u201337544.","DOI":"10.1074\/jbc.M305135200"},{"key":"key\n\t\t\t\t20171011194006_B72","doi-asserted-by":"crossref","unstructured":"Dohoney,K.M., Guillerm,C., Whiteford,C., Elbi,C., Lambert,P.F., Hager,G.L. and Brady,J.N. ( 2004 ) Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage. Oncogene , 23 , 49 \u201357.","DOI":"10.1038\/sj.onc.1207005"},{"key":"key\n\t\t\t\t20171011194006_B73","doi-asserted-by":"crossref","unstructured":"Prives,C. and Manley,J.L. ( 2001 ) Why is p53 acetylated? Cell , 107 , 815 \u2013818.","DOI":"10.1016\/S0092-8674(01)00619-5"},{"key":"key\n\t\t\t\t20171011194006_B74","doi-asserted-by":"crossref","unstructured":"Dumaz,N. and Meek,D.W. ( 1999 ) Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. , 18 , 7002 \u20137010.","DOI":"10.1093\/emboj\/18.24.7002"},{"key":"key\n\t\t\t\t20171011194006_B75","doi-asserted-by":"crossref","unstructured":"Sakaguchi,K., Herrera,J.E., Saito,S.i., Miki,T., Bustin,M., Vassilev,A., Anderson,C.W. and Appella,E. ( 1998 ) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. , 12 , 2831 \u20132841.","DOI":"10.1101\/gad.12.18.2831"},{"key":"key\n\t\t\t\t20171011194006_B76","doi-asserted-by":"crossref","unstructured":"Chen,L., Gilkes,D.M., Pan,Y., Lane,W.S. and Chen,J. ( 2005 ) ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J. , 24 , 3411 \u20133422.","DOI":"10.1038\/sj.emboj.7600812"},{"key":"key\n\t\t\t\t20171011194006_B77","doi-asserted-by":"crossref","unstructured":"Okamoto,K., Kashima,K., Pereg,Y. et al . ( 2005 ) DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation. Mol. Cell. Biol. , 25 , 9608 \u20139620.","DOI":"10.1128\/MCB.25.21.9608-9620.2005"},{"key":"key\n\t\t\t\t20171011194006_B78","doi-asserted-by":"crossref","unstructured":"Wiseman,A. ( 2005 ) p53 Protein is activated by Pin1: and also by Cu-SOD prion-like enzyme. Med. Hypotheses , 65 , 32 \u201334.","DOI":"10.1016\/j.mehy.2005.01.041"},{"key":"key\n\t\t\t\t20171011194006_B79","doi-asserted-by":"crossref","unstructured":"Jimenez,G.S., Khan,S.H., Stommel,J.M. and Wahl,G.M. ( 1999 ) p53 regulation by post-translational modification and nuclear retention in response to diverse stresses. Oncogene , 18 , 7656 \u20137665.","DOI":"10.1038\/sj.onc.1203013"},{"key":"key\n\t\t\t\t20171011194006_B80","doi-asserted-by":"crossref","unstructured":"Gostissa,M., Hofmann,T.G., Will,H. and Del Sal,G. ( 2003 ) Regulation of p53 functions: let's meet at the nuclear bodies. Curr. Opin. Cell. Biol. , 15 , 351 \u2013357.","DOI":"10.1016\/S0955-0674(03)00038-3"},{"key":"key\n\t\t\t\t20171011194006_B81","doi-asserted-by":"crossref","unstructured":"Ho,J.W., Song,J.Z. and Leung,Y.K. ( 2005 ) Activation of p53 by specific agents in potential cancer therapy. Curr. Med. Chem. Anti-Cancer Agents , 5 , 131 \u2013135.","DOI":"10.2174\/1568011053174819"},{"key":"key\n\t\t\t\t20171011194006_B82","doi-asserted-by":"crossref","unstructured":"Chene,P. ( 2001 ) Targeting p53 in cancer. Curr. Med. Chem. Anti-Cancer Agents , 1 , 151 \u2013161.","DOI":"10.2174\/1568011013354741"},{"key":"key\n\t\t\t\t20171011194006_B83","unstructured":"Roth,J.A., Swisher,S.G. and Meyn,R.E. ( 1999 ) p53 tumor suppressor gene therapy for cancer. Oncology (Williston Park) , 13 (Suppl. 5), 148 \u2013154."},{"key":"key\n\t\t\t\t20171011194006_B84","doi-asserted-by":"crossref","unstructured":"Chene,P. ( 2004 ) Inhibition of the p53-MDM2 interaction: targeting a protein\u2013protein interface. Mol. Cancer Res. , 2 , 20 \u201328.","DOI":"10.1158\/1541-7786.20.2.1"},{"key":"key\n\t\t\t\t20171011194006_B85","doi-asserted-by":"crossref","unstructured":"Chene,P. ( 2004 ) Inhibition of the p53-hdm2 interaction with low molecular weight compounds. Cell Cycle , 3 , 460 \u2013461.","DOI":"10.4161\/cc.3.4.797"},{"key":"key\n\t\t\t\t20171011194006_B86","doi-asserted-by":"crossref","unstructured":"Vassilev,L.T., Vu,B.T., Graves,B. et al . ( 2004 ) In vivo activation of the p53 pathway by pmall-molecule antagonists of MDM2. Science , 303 , 844 \u2013848.","DOI":"10.1126\/science.1092472"},{"key":"key\n\t\t\t\t20171011194006_B87","doi-asserted-by":"crossref","unstructured":"Haupt,S. and Haupt,Y. ( 2004 ) Manipulation of the tumor suppressor p53 for potentiating cancer therapy. Semin. Cancer Biol. , 14 , 244 \u2013252.","DOI":"10.1016\/j.semcancer.2004.04.003"},{"key":"key\n\t\t\t\t20171011194006_B88","doi-asserted-by":"crossref","unstructured":"Bykov,V.J., Selivanova,G. and Wiman,K.G. ( 2003 ) Small molecules that reactivate mutant p53. Eur. J. Cancer , 39 , 1828 \u20131834.","DOI":"10.1016\/S0959-8049(03)00454-4"},{"key":"key\n\t\t\t\t20171011194006_B89","doi-asserted-by":"crossref","unstructured":"Issaeva,N., Friedler,A., Bozko,P., Wiman,K.G., Fersht,A.R. and Selivanova,G. ( 2003 ) Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide. Proc. Natl Acad. Sci. USA , 100 , 13303 \u201313307.","DOI":"10.1073\/pnas.1835733100"},{"key":"key\n\t\t\t\t20171011194006_B90","unstructured":"Roth,J., Lenz-Bauer,C., Contente,A., Lohr,K., Koch,P., Bernard,S. and Dobbelstein,M. ( 2003 ) Reactivation of mutant p53 by a one-hybrid adaptor protein. Cancer Res. , 63 , 3904 \u20133908."},{"key":"key\n\t\t\t\t20171011194006_B91","doi-asserted-by":"crossref","unstructured":"Wilson,D.R. ( 2002 ) Viral-mediated gene transfer for cancer treatment. Curr. Pharm. Biotechnol. , 3 , 151 \u2013164.","DOI":"10.2174\/1389201023378445"},{"key":"key\n\t\t\t\t20171011194006_B92","unstructured":"Pirollo,K.F., Xu,L. and Chang,E.H. ( 2000 ) Non-viral gene delivery for p53. Curr. Opin. Mol. Ther. , 2 , 168 \u2013175."},{"key":"key\n\t\t\t\t20171011194006_B93","unstructured":"Anklesaria,P. ( 2000 ) Gene therapy: a molecular approach to cancer treatment. Curr. Opin. Mol. Ther. , 2 , 426 \u2013432."},{"key":"key\n\t\t\t\t20171011194006_B94","doi-asserted-by":"crossref","unstructured":"Gjerset,R.A. and Mercola,D. ( 2000 ) Sensitization of tumors to chemotherapy through gene therapy. Adv. Exp. Med. Biol. , 465 , 273 \u2013291.","DOI":"10.1007\/0-306-46817-4_24"},{"key":"key\n\t\t\t\t20171011194006_B95","doi-asserted-by":"crossref","unstructured":"Collot-Teixeira,S., Bass,J., Denis,F. and Ranger-Rogez,S. ( 2004 ) Human tumor suppressor p53 and DNA viruses. Rev. Med. Virol.14 , 301 \u2013319.","DOI":"10.1002\/rmv.431"},{"key":"key\n\t\t\t\t20171011194006_B96","doi-asserted-by":"crossref","unstructured":"Mahieux,R., Pise-Masison,C.A., Nicot,C., Green,P., Hall,W.W. and Brady,J.N. ( 2000 ) Inactivation of p53 by HTLV type 1 and HTLV type 2 Tax trans-activators. AIDS Res. Hum. Retroviruses , 16 , 1677 \u20131681.","DOI":"10.1089\/08892220050193137"},{"key":"key\n\t\t\t\t20171011194006_B97","doi-asserted-by":"crossref","unstructured":"Hatta,Y. and Koeffler,H.P. ( 2002 ) Role of tumor suppressor genes in the development of adult T cell leukemia\/lymphoma (ATLL). Leukemia , 16 , 1069 \u20131085.","DOI":"10.1038\/sj.leu.2402458"},{"key":"key\n\t\t\t\t20171011194006_B98","doi-asserted-by":"crossref","unstructured":"Tawara,M., Hogerzeil,S.J., Yamada,Y., Takasaki,Y., Soda,H., Hasegawa,H., Murata,K., Ikeda,S., Imaizumi,Y. and Sugahara,K. ( 2005 ) Impact of p53 aberration on the progression of Adult T-cell Leukemia\/Lymphoma. Cancer Lett. , In Press.","DOI":"10.1016\/j.canlet.2005.03.039"},{"key":"key\n\t\t\t\t20171011194006_B99","doi-asserted-by":"crossref","unstructured":"Newcomb,E.W. ( 1995 ) P53 gene mutations in lymphoid diseases and their possible relevance to drug resistance. Leuk. Lymphoma. , 17 , 211 \u2013221.","DOI":"10.3109\/10428199509056825"},{"key":"key\n\t\t\t\t20171011194006_B100","doi-asserted-by":"crossref","unstructured":"Takemoto,S., Trovato,R., Cereseto,A., Nicot,C., Kislyakova,T., Casareto,L., Waldmann,T., Torelli,G. and Franchini,G. ( 2000 ) p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14ARF-MDM2 loop in ex vivo and cultured adult T-cell leukemia\/lymphoma cells. Blood , 95 , 3939 \u20133944.","DOI":"10.1182\/blood.V95.12.3939.012k30_3939_3944"},{"key":"key\n\t\t\t\t20171011194006_B101","unstructured":"Reid,R.L., Lindholm,P.F., Mireskandari,A., Dittmer,J. and Brady,J.N. ( 1993 ) Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I. Oncogene , 8 , 3029 \u20133036."},{"key":"key\n\t\t\t\t20171011194006_B102","doi-asserted-by":"crossref","unstructured":"Cereseto,A., Diella,F., Mulloy,J., Cara,A., Michieli,P., Grassmann,R., Franchini,G. and Klotman,M. ( 1996 ) p53 functional impairment and high p21waf1\/cip1 expression in human T-cell lymphotropic\/leukemia virus type I-transformed T cells. Blood , 88 , 1551 \u20131560.","DOI":"10.1182\/blood.V88.5.1551.1551"},{"key":"key\n\t\t\t\t20171011194006_B103","doi-asserted-by":"crossref","unstructured":"Pise-Masison,C.A., Choi,K.S., Radonovich,M., Dittmer,J., Kim,S.J. and Brady,J.N. ( 1998 ) Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J. Virol. , 72 , 1165 \u20131170.","DOI":"10.1128\/JVI.72.2.1165-1170.1998"},{"key":"key\n\t\t\t\t20171011194006_B104","doi-asserted-by":"crossref","unstructured":"Akagi,T., Ono,H., Tsuchida,N. and Shimotohno,K. ( 1997 ) Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax1. FEBS. Lett. , 406 , 263 \u2013266.","DOI":"10.1016\/S0014-5793(97)00280-9"},{"key":"key\n\t\t\t\t20171011194006_B105","doi-asserted-by":"crossref","unstructured":"Ariumi,Y., Kaida,A., Lin,J.Y., Hirota,M., Masui,O., Yamaoka,S., Taya,Y. and Shimotohno,K. ( 2000 ) HTLV-1 tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestration. Oncogene , 19 , 1491 \u20131499.","DOI":"10.1038\/sj.onc.1203450"},{"key":"key\n\t\t\t\t20171011194006_B106","doi-asserted-by":"crossref","unstructured":"Pise-Masison,C.A., Mahieux,R., Radonovich,M., Jiang,H. and Brady,J.N. ( 2001 ) Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent. J. Biol. Chem. , 276 , 200 \u2013205.","DOI":"10.1074\/jbc.M005601200"},{"key":"key\n\t\t\t\t20171011194006_B107","doi-asserted-by":"crossref","unstructured":"Pise-Masison,C.A., Radonovich,M., Sakaguchi,K., Appella,E. and Brady,J.N. ( 1998 ) Phosphorylation of p53: a novel Pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. J. Virol. , 72 , 6348 \u20136355.","DOI":"10.1128\/JVI.72.8.6348-6355.1998"},{"key":"key\n\t\t\t\t20171011194006_B108","unstructured":"Gartenhaus,R.B. and Wang,P. ( 1995 ) Functional inactivation of wild-type p53 protein correlates with loss of IL-2 dependence in HTLV-I transformed human T lymphocytes. Leukemia , 9 , 2082 \u20132086."},{"key":"key\n\t\t\t\t20171011194006_B109","doi-asserted-by":"crossref","unstructured":"Jeang,K.T. ( 2001 ) Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-\u03baB. Cytokine Growth Factor Rev. , 12 , 207 \u2013217.","DOI":"10.1016\/S1359-6101(00)00028-9"},{"key":"key\n\t\t\t\t20171011194006_B110","doi-asserted-by":"crossref","unstructured":"Pise-Masison,C.A., Mahieux,R., Jiang,H., Ashcroft,M., Radonovich,M., Duvall,J., Guillerm,C. and Brady,J.N. ( 2000 ) Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-\u03baB pathway and is dependent on p53 phosphorylation. Mol. Cell. Biol. , 20 , 3377 \u20133386.","DOI":"10.1128\/MCB.20.10.3377-3386.2000"},{"key":"key\n\t\t\t\t20171011194006_B111","doi-asserted-by":"crossref","unstructured":"Lill,N.L., Grossman,S.R., Ginsberg,D., DeCaprio,J. and Livingston,D.M. ( 1997 ) Binding and modulation of p53 by p300\/CBP coactivators. Nature , 387 , 823 \u2013837.","DOI":"10.1038\/42981"},{"key":"key\n\t\t\t\t20171011194006_B112","unstructured":"Scolnick,D.M., Chehab,N.H., Stavridi,E.S., Lien,M.C., Caruso,L., Moran,E., Berger,S.L. and Halazonetis,T.D. ( 1997 ) CREB-binding protein and p300\/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res. , 57 , 3693 \u20133696."},{"key":"key\n\t\t\t\t20171011194006_B113","doi-asserted-by":"crossref","unstructured":"Van Orden,K., Giebler,H.A., Lemasson,I., Gonzales,M. and Nyborg,J.K. ( 1999 ) Binding of p53 to the KIX domain of CREB binding Protein. A potental link to human T-cell leukemia virus type1-associated leukmogenesis. J. Biol. Chem. , 274 , 26321 \u201326328.","DOI":"10.1074\/jbc.274.37.26321"},{"key":"key\n\t\t\t\t20171011194006_B114","doi-asserted-by":"crossref","unstructured":"Grossman,S.R. ( 2001 ) p300\/CBP\/p53 interaction and regulation of the p53 response. Eur. J. Biochem. , 268 , 2773 \u20132778.","DOI":"10.1046\/j.1432-1327.2001.02226.x"},{"key":"key\n\t\t\t\t20171011194006_B115","doi-asserted-by":"crossref","unstructured":"Livengood,J.A., Scoggin,K.E.S., Van Orden,K., McBryant,S.J., Edayathumangalam,R.S., Laybourn,P.J. and Nyborg,J.K. ( 2002 ) p53 transcriptional activity is mediated through the SRC1-interacting domain of CBP\/p300. J. Biol. Chem. , 277 , 9054 \u20139061.","DOI":"10.1074\/jbc.M108870200"},{"key":"key\n\t\t\t\t20171011194006_B116","unstructured":"Ravi,R., Mookerjee,B., van Hensbergen,Y., Bedi,G.C., Giordano,A., El-Deiry,W.S., Fuchs,E.J. and Bedi,A. ( 1998 ) p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res. , 58 , 4531 \u20134536."},{"key":"key\n\t\t\t\t20171011194006_B117","doi-asserted-by":"crossref","unstructured":"Wadgaonkar,R., Phelps,K.M., Haque,Z., Williams,A.J., Silverman,E.S. and Collins,T. ( 1999 ) CREB-binding protein is a nuclear integrator of nuclear factor-\u03baB and p53 signaling. J. Biol. Chem. , 274 , 1879 \u20131882.","DOI":"10.1074\/jbc.274.4.1879"},{"key":"key\n\t\t\t\t20171011194006_B118","doi-asserted-by":"crossref","unstructured":"Webster,G.A. and Perkins,N.D. ( 1999 ) Transcriptional cross talk between NF-\u03baB and p53. Mol. Cell. Biol. , 19 , 3485 \u20133495.","DOI":"10.1128\/MCB.19.5.3485"},{"key":"key\n\t\t\t\t20171011194006_B119","doi-asserted-by":"crossref","unstructured":"Ikeda,A., Sun,X., Li,Y., Zhang,Y., Eckner,R., Doi,T.S., Takahashi,T., Obata,Y., Yoshioka,K. and Yamamoto,K. ( 2000 ) p300\/CBP-dependent and\u2014independent transcriptional interference between NF-\u03baB RelA and p53. Biochem. Biophys. Res. Commun. , 272 , 375 \u2013379.","DOI":"10.1006\/bbrc.2000.2786"},{"key":"key\n\t\t\t\t20171011194006_B120","doi-asserted-by":"crossref","unstructured":"Hellin,A.C., Calmant,P., Gielen,J., Bours,V. and Merville,M.P. ( 1998 ) Nuclear factor-kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug. Oncogene , 16 , 1187 \u20131195.","DOI":"10.1038\/sj.onc.1201638"},{"key":"key\n\t\t\t\t20171011194006_B121","doi-asserted-by":"crossref","unstructured":"Wu,H. and Lozano,G. ( 1994 ) NF-\u03baB activation of p53. A potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. , 269 , 20067 \u201320074.","DOI":"10.1016\/S0021-9258(17)32128-2"},{"key":"key\n\t\t\t\t20171011194006_B122","doi-asserted-by":"crossref","unstructured":"Aleyasin,H., Cregan,S.P., Iyirhiaro,G., O'Hare,M.J., Callaghan,S.M., Slack,R.S. and Park,D.S. ( 2004 ) Nuclear factor-\u03baB modulates the p53 response in neurons exposed to DNA damage. J. Neurosci. , 24 , 2963 \u20132973.","DOI":"10.1523\/JNEUROSCI.0155-04.2004"},{"key":"key\n\t\t\t\t20171011194006_B123","doi-asserted-by":"crossref","unstructured":"Ryan,K.M., Ernst,M.K., Rice,N.R. and Vousden,K.H. ( 2000 ) Role of NF-\u03baB in p53-mediated programmed cell death. Nature , 404 , 892 \u2013897.","DOI":"10.1038\/35009130"},{"key":"key\n\t\t\t\t20171011194006_B124","doi-asserted-by":"crossref","unstructured":"Jeong,S.J., Radonovich,M., Brady,J.N. and Pise-Masison,C.A. ( 2004 ) HTLV-I Tax induces a novel interaction between p65\/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood , 104 , 1490 \u20131497.","DOI":"10.1182\/blood-2003-12-4174"},{"key":"key\n\t\t\t\t20171011194006_B125","doi-asserted-by":"crossref","unstructured":"Jeong,S.J., Pise-Masison,C.A., Radonovich,M.F., Park,H.U. and Brady,J.N. ( 2005 ) A novel NF-\u03baB pathway involving IKK\u03b2 and p65\/RelA Ser-536 phosphorylation results in p53 inhibition in the absence of NF-\u03baB transcriptional activity. J. Biol. Chem. , 280 , 10326 \u201310332.","DOI":"10.1074\/jbc.M412643200"},{"key":"key\n\t\t\t\t20171011194006_B126","doi-asserted-by":"crossref","unstructured":"Jeong,S.J., Pise-Masison,C.A., Radonovich,M.F., Park,H.U. and Brady,J.N. ( 2005 ) Activated AKT regulates NF-\u03baB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene , 24 , 6719 \u20136728.","DOI":"10.1038\/sj.onc.1208825"},{"key":"key\n\t\t\t\t20171011194006_B127","doi-asserted-by":"crossref","unstructured":"Coffer,P.J., Jin,J. and Woodgett,J.R. ( 1998 ) Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. , 335 , 1 \u201313.","DOI":"10.1042\/bj3350001"},{"key":"key\n\t\t\t\t20171011194006_B128","doi-asserted-by":"crossref","unstructured":"Kohn,K.W. and Pommier,Y. ( 2005 ) Molecular interaction map of the p53 and Mdm2 logic elements, which control the Off-On switch of p53 in response to DNA damage. Biochem. Biophys. Res. Commun. , 331 , 816 \u2013827.","DOI":"10.1016\/j.bbrc.2005.03.186"},{"key":"key\n\t\t\t\t20171011194006_B129","doi-asserted-by":"crossref","unstructured":"Dreyfus,D.H., Nagasawa,M., Gelfand,E.W. and Ghoda,L.Y. ( 2005 ) Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-\u03baB and p53 transcription factors. BMC Immunol. , 6 , 12 .","DOI":"10.1186\/1471-2172-6-12"},{"key":"key\n\t\t\t\t20171011194006_B130","doi-asserted-by":"crossref","unstructured":"Brown,K., Park,S., Kanno,T., Franzoso,G. and Siebenlist,U. ( 1993 ) Mutual regulation of the transcriptional activator NF-\u03baB and its Inhibitor, I\u03baB\u03b1. Proc. Natl Acad. Sci. USA , 90 , 2532 \u20132536.","DOI":"10.1073\/pnas.90.6.2532"},{"key":"key\n\t\t\t\t20171011194006_B131","doi-asserted-by":"crossref","unstructured":"Sun,S.C., Ganchi,P.A., Ballard,D.W. and Greene,W.C. ( 1993 ) NF-\u03baB controls expression of inhibitor I\u03baB\u03b1: evidence for an inducible autoregulatory pathway. Science , 259 , 1912 \u20131915.","DOI":"10.1126\/science.8096091"},{"key":"key\n\t\t\t\t20171011194006_B132","doi-asserted-by":"crossref","unstructured":"Yang,J.P., Hori,M., Takahashi,N., Kawabe,T., Kato,H. and Okamoto,T. ( 1999 ) NF-\u03baB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene , 18 , 5177 \u20135186.","DOI":"10.1038\/sj.onc.1202904"},{"key":"key\n\t\t\t\t20171011194006_B133","doi-asserted-by":"crossref","unstructured":"Iwabuchi,K., Li,B., Massa,H.F., Trask,B.J., Date,T. and Fields,S. ( 1998 ) Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2. J. Biol. Chem. , 273 , 26061 \u201326068.","DOI":"10.1074\/jbc.273.40.26061"},{"key":"key\n\t\t\t\t20171011194006_B134","doi-asserted-by":"crossref","unstructured":"Cao,Y., Hamada,T., Matsui,T., Date,T. and Iwabuchi,K. ( 2004 ) Hepatitis C virus core protein interacts with p53-binding protein, 53BP2\/Bbp\/ASPP2, and inhibits p53-mediated apoptosis. Biochem. Biophys. Res. Commun. , 315 , 788 \u2013795.","DOI":"10.1016\/j.bbrc.2004.01.124"},{"key":"key\n\t\t\t\t20171011194006_B135","doi-asserted-by":"crossref","unstructured":"Miyazato,A., Sheleg,S., Iha,H., Li,Y. and Jeang,K.T. ( 2005 ) Evidence for NF-\u03baB- and CBP-Independent repression of p53's transcriptional activity by human T-cell leukemia virus type 1 Tax in mouse embryo and primary human fibroblasts. J. Virol. , 79 , 9346 \u20139350.","DOI":"10.1128\/JVI.79.14.9346-9350.2005"},{"key":"key\n\t\t\t\t20171011194006_B136","doi-asserted-by":"crossref","unstructured":"Mulloy,J.C., Kislyakova,T., Cereseto,A. et al . ( 1998 ) Human T-cell lymphotropic\/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through Its CREB\/ATF functional domain. J. Virol. , 72 , 8852 \u20138860.","DOI":"10.1128\/JVI.72.11.8852-8860.1998"},{"key":"key\n\t\t\t\t20171011194006_B137","doi-asserted-by":"crossref","unstructured":"Kalkhoven,E. ( 2004 ) CBP and p300: HATs for different occasions. Biochem. Pharmacol. , 68 , 1145 \u20131155.","DOI":"10.1016\/j.bcp.2004.03.045"},{"key":"key\n\t\t\t\t20171011194006_B138","doi-asserted-by":"crossref","unstructured":"Chan,H.M. and La Thangue,N.B. ( 2001 ) p300\/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell. Sci. , 114 , 2363 \u20132373.","DOI":"10.1242\/jcs.114.13.2363"},{"key":"key\n\t\t\t\t20171011194006_B139","doi-asserted-by":"crossref","unstructured":"Van Orden,K. and Nyborg,J.K. ( 2000 ) Insight into the tumor suppressor function of CBP through the viral oncoprotein tax. Gene Expr. , 9 , 29 \u201336.","DOI":"10.3727\/000000001783992678"},{"key":"key\n\t\t\t\t20171011194006_B140","doi-asserted-by":"crossref","unstructured":"Azran,I., Jeang,K.T. and Aboud,M. ( 2005 ) High levels of cytoplasmic HTLV-1 Tax mutant proteins retain a Tax\u2013NF-kappaB\u2013CBP ternary complex in the cytoplasm. Oncogene , 24 , 4521 \u20134530.","DOI":"10.1038\/sj.onc.1208645"},{"key":"key\n\t\t\t\t20171011194006_B141","doi-asserted-by":"crossref","unstructured":"Vendel,A.C., McBryant,S.J. and Lumb,K.J. ( 2003 ) KIX-mediated assembly of the CBP-CREB-HTLV-1 tax coactivator-activator complex. Biochemistry , 42 , 12481 \u201312487.","DOI":"10.1021\/bi0353023"},{"key":"key\n\t\t\t\t20171011194006_B142","doi-asserted-by":"crossref","unstructured":"Georges,S.A., Giebler,H.A., Cole,P.A., Luger,K., Laybourn,P.J. and Nyborg,J.K. ( 2003 ) Tax recruitment of CBP\/p300, via the KIX domain, reveals a potent requirement for acetyltransferase activity that Is chromatin dependent and histone tail independent. Mol. Cell. Biol. , 23 , 3392 \u20133404.","DOI":"10.1128\/MCB.23.10.3392-3404.2003"},{"key":"key\n\t\t\t\t20171011194006_B143","doi-asserted-by":"crossref","unstructured":"Scoggin,K.E.S., Ulloa,A. and Nyborg,J.K. ( 2001 ) The oncoprotein Tax binds the SRC-1-interacting domain of CBP\/p300 to mediate transcriptional activation. Mol. Cell. Biol. , 21 , 5520 \u20135530.","DOI":"10.1128\/MCB.21.16.5520-5530.2001"},{"key":"key\n\t\t\t\t20171011194006_B144","doi-asserted-by":"crossref","unstructured":"Harrod,R., Kuo,Y.L., Tang,Y., Yao,Y., Vassilev,A., Nakatani,Y. and Giam,C.Z. ( 2000 ) p300 and p300\/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase\/activator-enhancer complex. J. Biol. Chem. , 275 , 11852 \u201311857.","DOI":"10.1074\/jbc.275.16.11852"},{"key":"key\n\t\t\t\t20171011194006_B145","doi-asserted-by":"crossref","unstructured":"Jiang,H., Lu,H., Schiltz,R.L., Pise-Masison,C.A., Ogryzko,V.V., Nakatani,Y. and Brady,J.N. ( 1999 ) PCAF interacts with Tax and stimulates Tax transactivation in a histone acetyltransferase-independent manner. Mol. Cell. Biol. , 19 , 8136 \u20138145.","DOI":"10.1128\/MCB.19.12.8136"},{"key":"key\n\t\t\t\t20171011194006_B146","doi-asserted-by":"crossref","unstructured":"Tabakin-Fix,Y., Huleihel,M. and Aboud,M. ( 2004 ) Activation of simian virus 40 promoter by HTLV-1 Tax protein: role of NF-\u03baB and CBP. Biocghem. Biophys. Res. Commun , 318 , 1052 \u20131056.","DOI":"10.1016\/j.bbrc.2004.04.137"},{"key":"key\n\t\t\t\t20171011194006_B147","doi-asserted-by":"crossref","unstructured":"Van Orden,K., Yan,J.P., Ulloa,A. and Nyborg,J.K. ( 1999 ) Binding of the human T-cell leukemia virus Tax protein to the co-activator CBP interfers with CBP-mediated transcriptional control. Oncogene , 18 , 3766 \u20133772.","DOI":"10.1038\/sj.onc.1202703"},{"key":"key\n\t\t\t\t20171011194006_B148","doi-asserted-by":"crossref","unstructured":"Lee,D.K., Kim,B.-C., Brady,J.N., Jeang,K.-T. and Kim,S.-J. ( 2002 ) Human T-cell lymphotropic virus type 1 Tax inhibits transforming growth factor-beta signaling by Blocking the association of Smad proteins with Smad-binding element. J. Biol. Chem. , 277 , 33766 \u201333775.","DOI":"10.1074\/jbc.M200150200"},{"key":"key\n\t\t\t\t20171011194006_B149","doi-asserted-by":"crossref","unstructured":"Nicot,C., Mahieux,R., Pise-Masison,C., Brady,J., Gessain,A., Yamaoka,S. and Franchini,G. ( 2001 ) Human T-cell lymphotropic virus Type 1 Tax represses c-Myb-dependent transcription through activation of the NF-\u03baB pathway and modulation of coactivator usage. Mol. Cell. Biol. , 21 , 7391 \u20137402.","DOI":"10.1128\/MCB.21.21.7391-7402.2001"},{"key":"key\n\t\t\t\t20171011194006_B150","doi-asserted-by":"crossref","unstructured":"Lemasson,I. and Nyborg,J.K. ( 2001 ) Human T-cell leukemia virus type I Tax repression of p73\u03b2 is mediated through competition for the C\/H1 domain of CBP. J. Biol. Chem. , 276 , 15720 \u201315727.","DOI":"10.1074\/jbc.M100131200"},{"key":"key\n\t\t\t\t20171011194006_B151","doi-asserted-by":"crossref","unstructured":"Mori,N., Morishita,M., Tsukazaki,T., Giam,C.Z., Kumatori,A., Tanaka,Y. and Yamamoto,N. ( 2001 ) Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor-\u03b2 signaling through interaction with CREB-binding protein\/p300. Blood , 97 , 2137 \u20132144.","DOI":"10.1182\/blood.V97.7.2137"},{"key":"key\n\t\t\t\t20171011194006_B152","doi-asserted-by":"crossref","unstructured":"Riou,P., Bex,F. and Gazzolo,L. ( 2000 ) The human T Cell leukemia\/lymphotropic virus type 1 Tax protein represses MyoD-dependent transcription by inhibiting MyoD-binding to the KIX domain of p300. A potential mechanism for Tax-mediated repression of the transcriptional activity of basic helix\u2013loop\u2013helix factors. J. Biol. Chem. , 275 , 10551 \u201310560.","DOI":"10.1074\/jbc.275.14.10551"},{"key":"key\n\t\t\t\t20171011194006_B153","doi-asserted-by":"crossref","unstructured":"Suzuki,T., Uchida-Toita,M. and Yoshida,M. ( 1999 ) Tax protein of HTLV-1 inhibits CBP\/p300-mediated transcription by interfering with recruitment of CBP\/p300 onto DNA element of E-box or p53 binding site. Oncogene , 18 , 4137 \u20134143.","DOI":"10.1038\/sj.onc.1202766"},{"key":"key\n\t\t\t\t20171011194006_B154","doi-asserted-by":"crossref","unstructured":"Chaudhry,S., Freebern,W.J., Smith,J.L., Butscher,W.G., Haggerty,C.M. and Gardner,K. ( 2002 ) Cross-regulation of T cell growth factor expression by p53 and the Tax oncogene. J. Immunol. , 169 , 6767 \u20136778.","DOI":"10.4049\/jimmunol.169.12.6767"},{"key":"key\n\t\t\t\t20171011194006_B155","doi-asserted-by":"crossref","unstructured":"Meertens,L., Pise-Masison,C., Quere,N., Brady,J., Gessain,A. and Mahieux,R. ( 2004 ) Utilization of the CBP but not the p300 co-activator by human T-lymphotropic virus type-2 Tax for p53 inhibition. Oncogene , 23 , 5447 \u20135458.","DOI":"10.1038\/sj.onc.1207719"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/27\/4\/673\/7090176\/bgi274.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T16:29:30Z","timestamp":1683304170000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/carcin\/article\/27\/4\/673\/2390980\/Functional-inactivation-of-p53-by-human-Tcell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,23]]},"references-count":155,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,11,23]]},"published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgi274","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,4]]},"published":{"date-parts":[[2005,11,23]]}}}